TCL Archive Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation September 27, 1985
TCL Archive New Creatinine Test Raises Questions About Accuracy Of Carboplatin Dosing October 8, 2010
TCL Archive Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development. January 13, 2006
TCL Archive Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside Of A Registry Trial July 4, 2014
